Published date: 28 February 2019
Closed early engagement
Contract summary
Industry
Animal products and related products - 03140000
Animal products, meat and meat products - 15100000
Blood products - 33141510
Animal blood - 33141580
Medicinal products for the blood, blood-forming organs and the cardiovascular system - 33620000
Medicinal products for the blood and blood-forming organs - 33621000
Vaccines for veterinary medicine - 33651690
Laboratory reagents - 33696500
Microbiological cultures - 33698100
Animal calls - 37413210
Laboratory services - 71900000
Research laboratory services - 73111000
Veterinary services - 85200000
Location of contract
East of England
Procurement reference
tender_199989/749939
Published date
28 February 2019
Closing date
14 March 2019
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The Agency requires the purchase of purified hyperimmune Equine Tetanus Antitoxin for use in the development of a replacement biological reference material.
An overview of the requirement is: hyperimmune equine tetanus antitoxin obtained from the repeated immunisation of horses with tetanus toxoid and toxin. The suitable material would have a potency of at least 1,500 IU/ml in a total volume of not less than 5 L and will be purified F(ab)2. Material to be supplied in 2019.
As far as we are aware there is only one supplier who is able to meet this very specific request. Potential suppliers if they feel they can meet the requirement should email Nawaz.habib@nibsc.org to register an interest.
If no submissions of potential interest are received by close of play 14 March 2019, it is then intended to perform a direct award without competition to the sole supplier we believe can deliver the required service.
More information
Links
-
- https://mhra.bravosolution.co.uk/web_mhra/login.html
- Tender notice
- MHRA bravo etendering portal Weblink
About the buyer
Address
NIBSC, Blanche Lane, South Mimms,
Potters Bar
EN6 3QG
England
Share this notice
Closing date: 14 March 2019